Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
MYCi975 is an inhibitor of MYC that blocks the interaction between Myc and Max, which leads to reduced Myc stability, thereby potentially enhancing the antitumor immune response, and inhibiting colony formation and tumor growth (PMID: 31679823).
|DrugClasses||c-MYC Inhibitor 11|
|CAS Registry Number||2289691-01-4|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Cytarabine + MYCi975||Cytarabine MYCi975||0||0|
|MYCi975 + unspecified PD-1 antibody||MYCi975 unspecified PD-1 antibody||0||0|